Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 10
Results: 14
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1383, doi. 10.1007/s00262-011-1036-0
- By:
- Publication type:
- Article
Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1397, doi. 10.1007/s00262-011-1044-0
- By:
- Publication type:
- Article
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1405, doi. 10.1007/s00262-011-1040-4
- By:
- Publication type:
- Article
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1419, doi. 10.1007/s00262-011-1028-0
- By:
- Publication type:
- Article
Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1431, doi. 10.1007/s00262-011-1047-x
- By:
- Publication type:
- Article
An ADP ribosylation factor-GTPase activating protein negatively regulates the production of proinflammatory mediators in response to lipopolysaccharide.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1439, doi. 10.1007/s00262-011-1048-9
- By:
- Publication type:
- Article
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1447, doi. 10.1007/s00262-011-1049-8
- By:
- Publication type:
- Article
Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1461, doi. 10.1007/s00262-011-1045-z
- By:
- Publication type:
- Article
Th17 and Th17-stimulated CD8 T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1473, doi. 10.1007/s00262-011-1054-y
- By:
- Publication type:
- Article
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1485, doi. 10.1007/s00262-011-1052-0
- By:
- Publication type:
- Article
Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1497, doi. 10.1007/s00262-011-1060-0
- By:
- Publication type:
- Article
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1373, doi. 10.1007/s00262-011-1068-5
- By:
- Publication type:
- Article
The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1503, doi. 10.1007/s00262-011-1074-7
- By:
- Publication type:
- Article
Combination of targeted therapy and immunotherapy in melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1359, doi. 10.1007/s00262-011-1079-2
- By:
- Publication type:
- Article